Skip to main content

Loading market data...

PFE

Pfizer Inc.

NYSE • United states

$29.85

-$0.26

(-0.86%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:04 GMT+0000

Management
Credibility
Score

Pfizer Inc. (PFE)

Unavailable

Quotes may be delayed

$170.14B

Market Cap

22,196,975

Volume

39.3

P/E Ratio

5.76%

Div Yield

Pfizer Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 66 HUDSON BOULEVARD EAST, NEW YORK, NY
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

17 Oct 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Pfizer Inc..

4 Aug 2026

Pfizer Inc. filed Form 10-Q

Pfizer Inc. submitted Form 10-Q to the SEC for the period ending Jun 28, 2026.

4 Aug 2026

Pfizer Inc. reported Operating or financial results

Pfizer Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

18 Jun 2026

Pfizer Inc. reported Regulation FD disclosure

Pfizer Inc. filed an 8-K covering Regulation FD disclosure.

18 Jun 2026

Pfizer Inc. reported A director or senior management change or compensation event

Pfizer Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$976.00M

Total assets (USD)$201.13B

Total liabilities (USD)$115.64B

Shareholders' equity (USD)$85.19B

Long-term debt (USD)$60.50B

Debt due within a year (USD)$2.61B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 28 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$15.03B	Unavailable	−$248.00M	−$0.04	10-Q · 4 Aug 2026
Q1 2026	$14.45B	Unavailable	$2.69B	$0.47	10-Q · 5 May 2026
Q4 2025	$17.56B	Unavailable	−$1.65B	Unavailable	10-K · 26 Feb 2026
Q3 2025	$16.65B	Unavailable	$3.54B	$0.62	10-Q · 4 Nov 2025
Q2 2025	$14.65B	Unavailable	$2.91B	$0.51	10-Q · 5 Aug 2025
Q1 2025	$13.72B	Unavailable	$2.97B	$0.52	10-Q · 5 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $29.62

-0.8% upside potential

📈

Strong Buy

Unavailable

👍

Buy

8

⏸️

Hold

13

📉

Sell

1

22 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 04:48 UTC Targets range 25.00–36.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

Verified Insider Transactions Unavailable

Director and insider transaction data is not ingested for this stock yet.

Top Shareholders

Vanguard Group Inc

541,346,182 shares

0.223% change

12/31/2025

Blackrock, Inc.

529,670,433 shares

6.305% change

6/30/2026

Vanguard Capital Management Llc

372,149,852 shares

0.736% change

6/30/2026

State Street Corp

307,090,897 shares

1.824% change

6/30/2026

Geode Capital Management, Llc

135,275,782 shares

1.283% change

6/30/2026

Vanguard Portfolio Management Llc

119,235,030 shares

2.142% change

6/30/2026

Fisher Asset Management, Llc

109,067,291 shares

3.909% change

6/30/2026

Morgan Stanley

96,345,452 shares

3.949% change

6/30/2026

Norges Bank

61,505,586 shares

-16.357% change

6/30/2026

Northern Trust Corp

59,084,573 shares

-4.743% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 04:48 UTC· 7 hours ago

Research coverage and investment tools

Pfizer Inc. (PFE) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$29.85 on 21 Oct 2026. That is 94% of the way from its 52-week low of US$23.62 to its 52-week high of US$30.25. It paid US$1.72 a share in dividends over the last 12 months, a dividend yield of 5.76%. The latest ex-dividend date on file is 24 Jul 2026. Its market capitalisation was US$170.14 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$15.03B	Unavailable	−$248.00M	−$0.04	—	—	—	10-Q · 4 Aug 2026 (opens in a new tab)
Q1 2026	$14.45B	Unavailable	$2.69B	$0.47	—	—	$2.18B	10-Q · 5 May 2026 (opens in a new tab)
Q4 2025	$17.56B	Unavailable	−$1.65B	Unavailable	—	—	—	10-K · 26 Feb 2026 (opens in a new tab)
Q3 2025	$16.65B	Unavailable	$3.54B	$0.62	—	—	—	10-Q · 4 Nov 2025 (opens in a new tab)
Q2 2025	$14.65B	Unavailable	$2.91B	$0.51	—	—	—	10-Q · 5 Aug 2025 (opens in a new tab)
Q1 2025	$13.72B	Unavailable	$2.97B	$0.52	—	—	$1.77B	10-Q · 5 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/4/2026	$0.77	$0.68	+13.2%
Mar 2026	5/5/2026	$0.75	$0.71	+5.6%
Dec 2025	2/3/2026	$0.66	$0.57	+15.8%
Sep 2025	11/4/2025	$0.87	$0.66	+31.8%

Cash and equivalents: $976.00M
Total assets: $201.13B
Total liabilities: $115.64B
Shareholders' equity: $85.19B
Long-term debt: $60.50B
Debt due within a year: $2.61B

SCHEDULE 13G · 17 Oct 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Pfizer Inc..
10-Q · 4 Aug 2026

Pfizer Inc. filed Form 10-Q (opens in a new tab)

Pfizer Inc. submitted Form 10-Q to the SEC for the period ending Jun 28, 2026.
8-K · 4 Aug 2026

Pfizer Inc. reported Operating or financial results (opens in a new tab)

Pfizer Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 18 Jun 2026

Pfizer Inc. reported Regulation FD disclosure (opens in a new tab)

Pfizer Inc. filed an 8-K covering Regulation FD disclosure.
8-K · 18 Jun 2026 · Management change

Pfizer Inc. reported A director or senior management change or compensation event (opens in a new tab)

Pfizer Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	541,346,182	0.223%
Blackrock, Inc.	6/30/2026	529,670,433	6.305%
Vanguard Capital Management Llc	6/30/2026	372,149,852	0.736%
State Street Corp	6/30/2026	307,090,897	1.824%
Geode Capital Management, Llc	6/30/2026	135,275,782	1.283%
Vanguard Portfolio Management Llc	6/30/2026	119,235,030	2.142%
Fisher Asset Management, Llc	6/30/2026	109,067,291	3.909%
Morgan Stanley	6/30/2026	96,345,452	3.949%
Norges Bank	6/30/2026	61,505,586	-16.357%
Northern Trust Corp	6/30/2026	59,084,573	-4.743%

Previous close: 30.11 USD
Day range: 29.69 – 30.09 USD
52-week range: 23.62 – 30.25 USD
Volume: 22,196,975
Market cap: $170.14B
Average volume: 27,470,701
P/E ratio: 39.3
EPS (FY 2025, diluted): 1.36 USD
Dividends (last 12 months): 1.72 USD
Dividend yield: 5.76%
Ex-dividend date: 24 Jul 2026
Shares outstanding: 5.70B
Beta (5Y monthly): 0.36

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:04 UTC· 15 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:05 UTC· 3 hours ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 08:05 UTC· 3 hours ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for PFE yet

Guidance history
Insider transactions

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.